COVID 19 and Ethnicity: Spot light on the global rheumatology issues in developing and developed countries.

COVID 19 and Ethnicity: Spot light on the global rheumatology issues in developing and developed countries.

Publication date: May 30, 2020

A key issue in the response to the coronavirus disease 2019 (COVID-19) pandemic is the internationally recognised observation that COVID-19 disproportionally affects the Black and Minority Ethnic Population (BAME) (1). We focus predominantly on the countries of the UK, USA, and India COVID-19 rheumatology challenges and examples. This unprecedented public health crisis started in China in Dec 2019, following an infection caused by a novel coronavirus strain, named as SARS-CoV2 (2). The World Health Organisation in March 2020 declared this public health emergency as a pandemic (2). COVID-19 pandemic has moved from country to country peaking at different times despite implementation of strict preventive measures, including complete lock down periods with varied success. Case fatality and mortality rates have been highly variable across nations as well as different ethnic groups (3).

Concepts Keywords
China Viruses
Coronavirus Articles
Developed Countries Health
India Coronaviridae
Infection Animal virology
Lock Zoonoses
Mortality Coronavirus
Pandemic Pandemic
Rheum
Rheumatology
SARS
Spot

Semantics

Type Source Name
disease MESH infection
disease MESH emergency
drug DRUGBANK Spinosad

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *